intermittent explosive disorder
Information
- Disease name
- intermittent explosive disorder
- Disease ID
- DOID:12401
- Description
- "An impulse control disorder that involves the episodic inability to control violent impulses with a disproportionate degree of aggressiveness." [url:https\://en.wikipedia.org/wiki/Intermittent_explosive_disorder]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00078754 | Completed | Phase 2 | A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder | May 2003 | October 2008 |
NCT00127400 | Completed | Phase 2 | A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED | February 2002 | July 2006 |
NCT00399698 | Completed | Phase 3 | Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. | May 1999 | June 2005 |
NCT00667212 | Completed | Phase 2 | Psychotherapy for Intermittent Explosive Disorder | August 2006 | December 2010 |
NCT02048241 | Completed | Phase 4 | Intuniv vs Placebo in the Treatment of Childhood Intermittent Explosive Disorder | July 2011 | December 2014 |
NCT02055638 | Completed | Phase 1/Phase 2 | Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder | May 2014 | May 2016 |
NCT05895513 | Not yet recruiting | Phase 2 | Pimavanserin and Aggression and Social Cognition. | January 2024 | January 2026 |
NCT06118567 | Recruiting | Phase 2 | Effect of Nitrous Oxide on Aggression. | September 6, 2022 | August 31, 2025 |
NCT06118580 | Recruiting | Phase 2 | Neural Correlates During Alcohol Intoxication | June 8, 2023 | August 31, 2026 |
NCT06275607 | Recruiting | N/A | Maladaptive Anger Treatment | February 7, 2024 | December 31, 2025 |
NCT00282165 | Terminated | Phase 4 | Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order | November 2006 | December 2012 |
NCT03420222 | Terminated | Phase 2 | Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder | January 18, 2018 | December 28, 2018 |
NCT04819230 | Unknown status | N/A | A Cognitive Bias Modification RCT for Aggression | May 2021 | June 2023 |
- Disase is a (Disease Ontology)
- DOID:10937
- Cross Reference ID (Disease Ontology)
- ICD10CM:F60.3
- Cross Reference ID (Disease Ontology)
- ICD10CM:F63.81
- Cross Reference ID (Disease Ontology)
- ICD9CM:301.3
- Cross Reference ID (Disease Ontology)
- ICD9CM:312.34
- Cross Reference ID (Disease Ontology)
- MESH:D007174
- Cross Reference ID (Disease Ontology)
- NCI:C94332
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:192096007
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:268757006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0021776
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0152183
- Exact Synonym (Disease Ontology)
- explosive personality disorder